お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
617669

デュシェンヌ型筋ジストロフィー (DMD) :競合情勢

Duchenne Muscular Dystrophy (DMD): Competitive Landscape to 2026

出版日: | 発行: GlobalData | ページ情報: 英文 49 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.53円
デュシェンヌ型筋ジストロフィー (DMD) :競合情勢
出版日: 2018年01月31日
発行: GlobalData
ページ情報: 英文 49 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、デュシェンヌ型筋ジストロフィー (DMD) 治療薬について調査分析し、パイプライン情勢、治験情勢、商業的情勢について、体系的な情報を提供しています。

第1章 序文

第2章 エグゼクティブサマリー

第3章 イントロダクション

第4章 パイプラインの評価

  • パイプラインの概要
  • パイプライン製品:地域/国別
  • パイプライン製品:分子タイプ・標的別
  • 薬剤レビューの指定
  • 臨床開発中の製品

第5章 治験の評価

  • 治験の概要
  • 治験の主要スポンサー
  • 治験の内訳:地域別
  • 治験の成功率
  • 治療分野の見通し
  • 登録アナリティクス

第6章 商業的評価

  • 主な上市製品
  • 現在・将来の企業

第7章 競合情勢の分析

  • イベント・区分の概要
  • 米国
  • EU5ヶ国・日本

第8章 付録

目次
Product Code: GDHC001CL

Duchenne Muscular Dystrophy (DMD) is a rare, fatal recessive X-linked genetic disorder affecting predominantly males. It occurs as a result of mutations in the dystrophin gene that leads to the deficiency of the protein dystrophin, which causes the progressive weakness and degeneration of the muscles.

This report provides an assessment of the pipeline, clinical, and commercial landscape of DMD. Overall, GlobalData expects new drug approvals to drive DMD market growth over the next decade (2016-2026).

Scope:

This report combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.Components of the slide deck include -

  • Epidemiologic Overview: diagnosed prevalent cases, and epidemiological population breakdown
  • Pipeline Assessment: regional breakdown, promising late-stage products, early-stage pipeline by molecule type
  • Clinical Trials Assessment: trial breakdown by phase, leading industry and non-industry sponsors, enrollment analytics
  • Commercial Assessment: leading marketed products, current and future players
  • Competitive Landscape Analysis: key market events (2016-2026).

Reasons to buy:

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global DMD market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global DMD market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Gain insights to help plan your clinical trials and develop an idea about the enrollment analytics for the DMD population.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

1. Preface

  • 1.1. Table of Contents
  • 1.2. Abbreviations
  • 1.3. Related Reports

2. Executive Summary

  • 2.1. Key Findings
  • 2.2. Key Events

3. Introduction

  • 3.1. Report Scope
  • 3.2. Disease Definition and Epidemiology Overview

4. Pipeline Assessment

  • 4.1. Pipeline Overview
  • 4.2. Pipeline Products by Region/Country
  • 4.3. Pipeline Products by Molecule Type and Target
  • 4.4. Drug Review Designations
  • 4.5. Products in Clinical Development

5. Clinical Trial Assessment

  • 5.1. Clinical Trials Overview
  • 5.2. Top Sponsors of Clinical Trials in DMD
  • 5.3. Trial Breakdown by Region
  • 5.4. Trials Success Rate
  • 5.5. Therapy Area Perspective
  • 5.6. Enrollment Analytics

6. Commercial Assessment

  • 6.1. Leading Marketed Products
  • 6.2. Current & Future Players

7. Competitor Landscape Analysis (2016-2026)

  • 7.1. Events and Segmentation Overview
  • 7.2. US
  • 7.3. 5EU and Japan

8. Appendix

  • 8.1. Sources
  • 8.2. Methodology
  • 8.3. Key Events Included in the Analysis
  • 8.4. About the Authors
  • 8.5. About GlobalData
  • 8.6. Contact Us
  • 8.7. Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.